IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia.
Clara Vásquez VelásquezGraciela RussomandoEmilio E EspínolaZunilda SanchezKota MochizukiYelin RocaJimmy RevolloAngelica GuzmanBenjamín QuirogaSusana Rios MorganRoberto Vargas OrtizAlberto Zambrana OrtegaEida EspinozaJuan Eiki NishizawaMohamed Gomaa KamelMihoko KikuchiShusaku MizukamiKesara Na-BangchangNguyen Tien HuyKenji HirayamaPublished in: PLoS neglected tropical diseases (2019)
Plasma levels of IL-17A might be a bio-marker for detecting persistent infection of T. cruzi and its chronic inflammation.